Anidulafungin Labatec 100 mg, Poudre pour solution à diluer pour perfusion

7680677560019 CH-67756 Puder
Anidulafungin Labatec 100 mg, Poudre pour solution à diluer pour perfusion
Anidulafungin Labatec 100 mg, Poudre pour solution à diluer pour perfusion
Anidulafungin Labatec 100 mg, Poudre pour solution à diluer pour perfusion
1 / 3
google

Article details

Package size
1
Selling units
1
Measure
Durchstechflasche(n)
Galenic form
Puder
Galenic group
Spray/Puder

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
18/08/2022
Summary of Product Characteristics
Français
18/08/2022
Summary of Product Characteristics
Italien
18/08/2022

Detailed composition

Substance Quantity Type Category
PRC
100.0 MG Substance Wirkstoff (Principe actif)
PRC
100.0 MG Substance HBESI
PRC
- Substance HNIDK
PRC
- Substance HNIDK
PRC
- Substance HNIDK
PRC
- Substance HNIDK
PRC
- Substance HBESI
PRC
- Substance HNIDK

Reimbursement information

Public price
CHF 381.95
Specialties list
Yes
Generic
Yes

Reimbursement limitation

SL addition date: 01/03/2022

Authorization holder

Labatec Pharma SA

1217 Meyrin

Authorization information

Swissmedic authorization number
67756
Drug name
Anidulafungin Labatec 100 mg, Poudre pour solution à diluer pour perfusion
Galenic form
PULPI
ATC Code
J02AX06
Authorization status
Z
Dispensing category
A
First authorization
21/12/2020
Authorization expiration date
31/12/9999
IT Number
08.06.0.
Domain
Human medicine

Package details

Description (FR)
ANIDULAFUNGIN Labatec subst sèche 100 mg flac
Description (DE)
ANIDULAFUNGIN Labatec Trockensub 100 mg Durchstf
Market launch
21/12/2020
Narcotic (BTM)
No

Original drug

Ecalta, Pulver zur Herstellung einer Infusionslösung
GTIN: 7680583250035
CHF 442.80
View original

Other package sizes (1)

ANIDULAFUNGIN Labatec subst sèche 100 mg 5 pce
5 DUR
GTIN: 7680677560026
View